epigallocatechin gallate has been researched along with Pre-Eclampsia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; Jia, N; Li, H; Shi, J; Sun, Q; Wang, J | 1 |
| Peng, J; Wang, X; Xiang, L; Yang, X; Zhong, M; Zhu, Y | 1 |
| Guo, JJ; Shi, DD; Wang, N; Zhou, L | 1 |
1 trial(s) available for epigallocatechin gallate and Pre-Eclampsia
| Article | Year |
|---|---|
Epigallocatechin gallate enhances treatment efficacy of oral nifedipine against pregnancy-induced severe pre-eclampsia: A double-blind, randomized and placebo-controlled clinical study.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Catechin; Double-Blind Method; Female; Humans; Nifedipine; Pre-Eclampsia; Pregnancy; Treatment Outcome | 2018 |
2 other study(ies) available for epigallocatechin gallate and Pre-Eclampsia
| Article | Year |
|---|---|
The Efficacy Mechanism of Epigallocatechin Gallate against Pre-Eclampsia based on Network Pharmacology and Molecular Docking.
Topics: Catechin; Drugs, Chinese Herbal; Female; Humans; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; Pre-Eclampsia; Pregnancy | 2022 |
Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia.
Topics: Angiogenesis Inhibitors; Catechin; Cell Hypoxia; Cell Line; Cell Survival; Down-Regulation; Female; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Pre-Eclampsia; Pregnancy | 2020 |